Read twice and referred to the Committee on the Judiciary.
The bill amends the Controlled Substances Act to add a broad category of "fentanyl-related substances" to Schedule I. It defines that category by listing several structural modifications to fentanyl (isomers, esters, ethers, salts, and specific ring and substituent changes).
Progressives emphasize criminalization and research barriers
Relative to its intended legislative type, this bill performs a clear substantive amendment to the Controlled Substances Act by creating a broad Schedule I listing for a defined class of fentanyl-related substances, with detailed structural language to capture many analogues.
The bill amends the Controlled Substances Act to add a broad category of "fentanyl-related substances" to Schedule I.
It defines that category by listing several structural modifications to fentanyl (isomers, esters, ethers, salts, and specific ring and substituent changes).
The schedule addition takes effect one day after enactment.
Narrow policy aim increases plausibility, but broad chemical language, lack of exemptions, and implementation concerns lower enactment probability.
Relative to its intended legislative type, this bill performs a clear substantive amendment to the Controlled Substances Act by creating a broad Schedule I listing for a defined class of fentanyl-related substances, with detailed structural language to capture many analogues.
Progressives emphasize criminalization and research barriers
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize criminalization and research barriers
Likely cautious or skeptical: supports reducing overdoses but concerned this Schedule I listing is overly broad and criminalizes conduct while hindering research and treatment-focused responses.
Will view the lack of explicit research or medical exemptions as a major problem.
May call for coupling criminal measures with treatment, harm reduction, and research safeguards.
Generally supportive of the goal to curb fentanyl analog harms but wary of the bill's breadth and implementation details.
Would favor narrower statutory language, clear exemptions for research, and accompanying resources for enforcement and public health.
Sees need for legislative fixes to avoid unintended consequences.
Likely strongly supportive: views the bill as necessary to close a major loophole exploited by traffickers of fentanyl analogs and to strengthen law enforcement tools.
Appreciates the broad structural language that prevents rapid chemical workarounds.
Less focused on research burdens or treatment funding.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow policy aim increases plausibility, but broad chemical language, lack of exemptions, and implementation concerns lower enactment probability.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize criminalization and research barriers
Narrow policy aim increases plausibility, but broad chemical language, lack of exemptions, and implementation concerns lower enactment prob…
Relative to its intended legislative type, this bill performs a clear substantive amendment to the Controlled Substances Act by creating a broad Schedule I listing for a defined class of fentanyl-related substances, wit…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.